Here are three insights:
1. The accelerated neutral atom beam-treated PEEKplus technology is designed to enhance PEEK interbody spinal fusion devices’ bioactivity by creating a nanotextured PEEK surface.
2. PEEKplus is the only FDA-cleared nanotextured surface on a PEEK interbody device. “To enable bioactivity and initiate the osseointegration process, the surface of the interbody device must be hydrophilic; however, unaltered PEEK is hydrophobic by nature. Vallum addressed this issue by altering the PEEK material at the nanoscale to make it hydrophilic without any coating or chemicals or creating porosity,” said Frost & Sullivan Global Program Director Sowmya Rajagopalan.
3. Vallum’s ANAB processor superimposes nanoscale concavities directly onto the surface of the PEEK device to create 20- to 50-nanometer concavities. It is designed to convert any preexisting PEEK interbody fusion device into a PEEKplus device.
More articles on surface technology:
NuVasive earns FDA approval for PEEK cervical spine interbody: 5 insights
26th private payer establishes positive exclusive coverage for SI-Bone’s iFuse Implant System
joimax to introduce 3D-printed implants, navigation system & more
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
